HFM is a Biotech organization based in California and Switzerland, focusing on the development of novel medications in the fields of virology, immunology, and oncology, particularly in response to COVID-19 since December 2019. The company is addressing the challenges posed by both acute and chronic cases of COVID-19. Although there are some medications available in the market, their limited usage is attributed to inefficacy and challenging prescription protocols. Furthermore, it is noted that vaccines alone may not provide a comprehensive solution.